Recordati Makes Good Start to 2022 As Cold & Flu Sales Rebound
Italy's Recordati reports a double-digit rise in OTC sales for the first quarter of 2022, reflecting improved sales of cold & flu products and dietary supplements, particularly in France and its domestic market.
You may also be interested in...
Italy's Recordati attributed a solid rise in OTC sales in 2021 to the recovery of the European market as the COVID-19 pandemic loosened its grip.
India's Sun Pharma has expanded the portfolio of its Romanian subsidiary Terapia with the acquisition of the Uractiv urinary tract health brand.
Futura Medical's novel OTC topical erectile dysfunction treatment MED3000 will be launched across numerous European markets by France's Cooper Consumer Health.